Physicians More Likely To Report Drug Safety Information Through Electronic Health Records System (Press release issued by Pfizer)
Novo Nordisk Licenses ZymoGenetics’ IP, Antibody (The Pink Sheet)
This is copyright protected information, to receive the full article, please click here to sign up and register.
Novartis presents 6-month results from its EVEREST study for PCV (Medical News.Net)
Protalix Biotherapeutics completes NDA submission for taliglucerase alfa (Medical News.Net)
Roche reports progress in breast cancer treatment (Reuters)
Knopp Neurosciences Reports Presentation of Encouraging Clinical Trends in a Phase 2 Study of KNS-760704 in ALS (Business Wire)
Pfizer Seeks Boost From Copying Biotechnology Drugs (Update2) (Bloomberg)
Drug Candidates in Pipeline Offer Potential for Parkinson’s Disease Therapeutics Market, Says Frost & Sullivan (PR Newswire)
SUBSCRIBE